Biotechnology Companies By Roa

Return On Asset
ROAEfficiencyMarket RiskExp Return
1PTCT PTC Therapeutics
0.24
(0.01)
 4.45 
(0.07)
2ADMA ADMA Biologics
0.22
(0.03)
 4.04 
(0.13)
3NVAX Novavax
0.2
 0.01 
 6.26 
 0.07 
4CVAC CureVac NV
0.2
 0.18 
 6.38 
 1.15 
5CPRX Catalyst Pharmaceuticals
0.19
(0.08)
 2.41 
(0.19)
6HALO Halozyme Therapeutics
0.19
(0.05)
 4.49 
(0.21)
7RIGL Rigel Pharmaceuticals
0.18
 0.04 
 3.05 
 0.11 
8EXEL Exelixis
0.18
 0.09 
 3.50 
 0.33 
9CTMX CytomX Therapeutics
0.16
 0.17 
 18.27 
 3.08 
10MDXG MiMedx Group
0.14
(0.13)
 2.61 
(0.34)
11UTHR United Therapeutics
0.13
(0.03)
 2.62 
(0.08)
12INDV Indivior PLC Ordinary
0.13
 0.19 
 3.39 
 0.64 
13GILD Gilead Sciences
0.12
(0.02)
 2.11 
(0.04)
14IRWD Ironwood Pharmaceuticals
0.12
(0.07)
 8.79 
(0.63)
15THTX Theratechnologies
0.12
 0.13 
 7.80 
 1.04 
16VRTX Vertex Pharmaceuticals
0.12
(0.07)
 1.97 
(0.14)
17ALKS Alkermes Plc
0.12
(0.09)
 2.24 
(0.20)
18GMAB Genmab AS
0.12
 0.03 
 2.30 
 0.08 
19PBYI Puma Biotechnology
0.11
 0.04 
 3.67 
 0.15 
20MNKD MannKind Corp
0.11
(0.15)
 2.63 
(0.40)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time. Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.